Mary-Anne Young

Head

Garvan Institute of Medical Research

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Medical Science Medical Science professors in Australia

Contact this professor

ORCID

Google Scholar

About

Mary-Anne Young is the Head at the Garvan Institute of Medical Research in Australia. Her research interests focus on genomic testing, specifically the implementation of polygenic risk scores in hereditary cancer assessment, and the integration of genomics into healthcare. She has authored several recent articles addressing public perspectives on genetic testing and strategies for supporting genomic screening uptake.

Mary-Anne Young

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Using a behaviour-change approach to support uptake of population genomic screening and management options for breast or prostate cancer

Standardization, Education, and Resourcing: The Way Forward for Implementing Polygenic Risk Scores in Hereditary Breast and Ovarian Cancer

Older research participants are motivated to receive genetic results for the benefit of younger relatives

Considering Clinical Implementation of Polygenic Scores in Hereditary Cancer Risk Assessment: Recipients' Perspectives on Influencing Factors and Strategies.

Defining next steps in the clinical implementation of polygenic scores: A landscape analysis of professional groups' perspectives.

Systematic review of the uptake and outcomes from returning secondary findings to adult participants in research genomic testing.

Publics’ knowledge of, attitude to and motivation towards health-related genomics: a scoping review

Navigating genomic testing: Evaluation of an e-learning module with general practitioners

Using polygenic risk modification to improve breast cancer prevention: study protocol for the PRiMo multicentre randomised controlled trial

Genetic counsellors: facilitating the integration of genomics into health care.

Models of communication for polygenic scores and associated psychosocial and behavioral effects on recipients: A systematic review.

Development and evaluation of a novel educational program for providers on the use of polygenic risk scores

TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members

The Clinical and Psychosocial Outcomes for Women Who Received Unexpected Clinically Actionable Germline Information Identified through Research: An Exploratory Sequential Mixed-Methods Comparative Study.

Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals

My Research Results: a program to facilitate return of clinically actionable genomic research findings

Unselected Women's Experiences of Receiving Genetic Research Results for Hereditary Breast and Ovarian Cancer: A Qualitative Study.

Collaborators (9)

Stephanie Best

Yeh Chen Lee

Paul James

Sarah Kummerfeld

Roger Milne

Gisela Mir Arnau

Chris Jacobs

Aideen McInerney‐Leo

Erin Turbitt

How do I reach out?

Meet Kite AI